Martin Henrik Maurer

Martin H. Maurer graduated from medical school at the University of Heidelberg, Germany, and McGill University, Montréal, Canada, in 1999 – receiving his MD in 1999. As a post-doctoral fellow in 2003 at the Johns Hopkins University, Baltimore, Md., USA, he concentrated on neurological diseases and was appointed Assistant Professor of Physiology in 2005 and Associate Professor of Physiology in 2007 at the University of Heidelberg. From 2007-08, he was a research group leader in the biotech industry. In 2009-10, he did clinical work in pediatrics, and from 2011-17 in child and adolescent psychiatry. He is now at a private practice at the MVZ Krankenhaus Bad Cannstatt gGmbH in Stuttgart, Germany.

2books edited

2chapters authored

Latest work with IntechOpen by Martin Henrik Maurer

Though considerable amount of research, both pre-clinical and clinical, has been conducted during recent years, Amyotrophic Lateral Sclerosis (ALS) remains one of the mysterious diseases of the 21st century. Great efforts have been made to develop pathophysiological models and to clarify the underlying pathology, and with novel instruments in genetics and transgenic techniques, the aim for finding a durable cure comes into scope. On the other hand, most pharmacological trials failed to show a benefit for ALS patients. In this book, the reader will find a compilation of state-of-the-art reviews about the etiology, epidemiology, and pathophysiology of ALS, the molecular basis of disease progression and clinical manifestations, the genetics familial ALS, as well as novel diagnostic criteria in the field of electrophysiology. An overview over all relevant pharmacological trials in ALS patients is also included, while the book concludes with a discussion on current advances and future trends in ALS research.

Go to the book